Articles
Viral Vector Vaccine Manufacture: A Glance at the Future...
Today, within the pandemic situation, mRNA or gene therapy is no longer unknown to us. Whether you are a gardener, computer engineer, or dentist, we...
Articles
Accelerating Asia’s digital GMP transformation with industry 4.0 technologies
In the IDC Info Brief: "Good Manufacturing Practices for Asia/Pacific Pharmaceutical Companies: Accelerating Transformation with Manufacturing 4.0” published in June 2021 and sponsored by Cognizant...
Articles
How the Pharmaceutical Industry can keep up with regulatory...
Being aware that maintenance has a big influence on both compliance of pharmaceutical processes and the quality of products, observant business owners are beginning to...
Articles
Samsung Biologics – how are CDMOs affected post Covid...
Impact of COVID-19 on Biopharma CDMO Market: Innovation and Investment
The COVID-19 pandemic has strained resources across the globe and impacted nearly every sector. Arguably, it...
Articles
AES Clean Technology Post-COVID Supply Chain Commentary
OCT 2021 At AES Clean Technology, we had front-row seats to many of the challenges and triumphs created by the pandemic. There were several factors...
Articles
INCOG: Supply chain commentary
Tedd Green, COO at INCOG Biopharma Services discusses the supply chain challenges that pharmaceutical companies have faced due to the COVID-19 pandemic and what the...
Articles
ChargePoint Technology: Post-COVID Supply Chain Commentary
The pharmaceutical industry and its supply chain have both undergone considerable upheaval due to the COVID-19 pandemic. The closure of factories in Asia producing the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.